Mayur Raval has taken on a new role as Quality Specialist – CQV at SISPQ Consultancy, bringing over a decade of rich pharmaceutical quality experience to the consultancy’s dynamic team. Based in Ahmedabad, Mayur began this role in June 2025, where he is now leading quality system development, CQV (Commissioning, Qualification, and Validation) documentation, greenfield project execution, and compliance management across pharmaceutical setups.
Prior to this engagement, Mayur served as Quality Assurance Manager at BioMatrix Healthcare Pvt. Ltd., where he played a pivotal role in QA leadership, cleaning validation, and equipment qualification. During his nearly two-year stint there, he helmed the QA section, overseeing regulatory compliance and quality enhancement initiatives critical to the organization’s operational excellence.
Mayur’s longest and most formative tenure was with Intas Pharmaceuticals, where he progressed through multiple quality roles over more than 11 years. From handling QMS and regulatory requirements to leading audits and driving CAPA strategies, he built a robust foundation in quality assurance and regulatory frameworks that now serves him well in his consultancy role. His hands-on experience in documentation, qualification protocols, and quality metrics has enabled him to become a trusted domain expert.
In his current role at SISPQ Consultancy, Mayur is working in a hybrid capacity, leading CQV and quality initiatives for turnkey pharmaceutical projects. His key responsibilities include the development of quality systems from scratch, ensuring audit readiness, and aligning project delivery with global compliance standards. Known for his sharp focus on continuous improvement and cross-functional collaboration, he is set to make a strong impact in optimizing quality infrastructures for clients.
With a proven track record across renowned pharmaceutical organizations, Mayur Raval’s latest move to SISPQ Consultancy signals a deepened commitment to advancing quality and regulatory excellence within the pharma sector. His expertise is expected to play a crucial role in helping companies meet rigorous global standards while driving innovation and operational integrity.